Amerise Biosciences Ltd

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Monday 8th August 2023 at the Registered Office of the Company and transacted the following major businesses: <BR> <BR> 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2023.<BR> <BR> The board meeting concluded on 04.15. P.M<BR> <BR> Please take the above intimation in your records.<BR> <BR> Thanking You<BR>